Concepedia

Laura Godfrey

LG

Statistics

Publications

13

Citations

1K

H-Index

13

Active since

1991

Affiliations

University of Oxford(Current)

MRC Weatherall Institute of Molecular Medicine

University of California, San Francisco

Oxford BioMedica (United Kingdom)

The University of Texas MD Anderson Cancer Center

Laura Godfrey is an author at University of Oxford specializing in cell biology, medicine, and transcriptional regulation.

ORCID

Top concepts

Publications per year

1991–2023

13

Publications

13

DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation

Laura Godfrey, Nicholas T. Crump, Ross Thorne et al. · Nature Communications · 2019 · 163 citations · Full text

MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199

Juliana M. Benito, Laura Godfrey, Kensuke Kojima et al. · Cell Reports · 2015 · 152 citations · Full text

, , +15

BET inhibition disrupts transcription but retains enhancer-promoter contact

Nicholas T. Crump, Erica Ballabio, Laura Godfrey et al. · Nature Communications · 2021 · 123 citations · Full text

Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs

Sorcha O’Byrne, Natalina Elliott, Siobhan Rice et al. · Blood · 2019 · 92 citations · Full text

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia

Jon Kerry, Laura Godfrey, Emmanouela Repapi et al. · Cell Reports · 2017 · 91 citations · Full text

, , +10

1–5 of 13